Associate Professor Pawel Rubis
John Paul II Hospital, Krakow (Poland)
Member of:
/f/125658/3386x1417/951de003e4/hfa-acronym-name-rgb.png)
Natural history of myocardial fibrosis in dilated cardiomyopathy
Event: ESC Congress 2022
Topic: Dilated Cardiomyopathy
Session: Non-ischaemic cardiomyopathy: novel insights
Interstitial fibrosis, quantified with magnetic resonance-derived extracellular volume, is an independent predictor of ventricular arrhythmic burden in dilated cardiomyopathy
Event: Heart Failure 2021
Topic: Dilated Cardiomyopathy
Session: ePoster session
Associations between myocardial fibrosis-linked microRNAs and serum markers of fibrosis in dilated cardiomyopathy
Event: Heart Failure 2018
Topic: Pathophysiology
Session: Basic Science
Regardless of the fibrosis status 12-month kinetics of serum markers of fibrosis are not different in dilated cardiomyopathy patients
Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure
Topic: Biomarkers, other
Session: Biomarkers
Comparison of 12-month kinetics of serum markers of collagen synthesis, transforming growth factor and connective tissue growth factor between patients with recent and chronic dilated cardiomyopathy
Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure
Topic: Dilated cardiomyopathy
Session: Basic Science - Animal experimentation
Panel of serum markers of fibrosis does not contribute to prognosis in dilated cardiomyopathy
Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure
Topic: Prognosis (using biomarkers)
Session: Biomarkers
Fibrosis of extracellular matrix is inversely related with left ventricular volumes in dilated cardiomyopathy
Event: ESC Congress 2016
Topic: Cardiomyopathies
Session: Cardiomyopathy
Comparison of endomyocardial biopsy results between early and late dilated cardiomyopathy
Event: ESC Congress 2016
Topic: Cardiomyopathies
Session: Cardiomyopathy
